Bispecific antibodies as monotherapy or in combinations for hematological malignancies: latest updates from the EHA 2023 annual meeting
.
Source: Expert Opinion on Biological Therapy - Category: Drugs & Pharmacology Authors: Xingchen LiPeng ZhangHao SunLijie HanZhongxing JiangJifeng Yua Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Chinab Department of Orthopedics, Affiliated Hospital of Changchun University of Traditional Chines Source Type: research